IL141563A0 - Pharmaceutical compositions containing zot or zonulin - Google Patents

Pharmaceutical compositions containing zot or zonulin

Info

Publication number
IL141563A0
IL141563A0 IL14156399A IL14156399A IL141563A0 IL 141563 A0 IL141563 A0 IL 141563A0 IL 14156399 A IL14156399 A IL 14156399A IL 14156399 A IL14156399 A IL 14156399A IL 141563 A0 IL141563 A0 IL 141563A0
Authority
IL
Israel
Prior art keywords
zot
zonulin
antigen
specific
pharmaceutical compositions
Prior art date
Application number
IL14156399A
Other languages
English (en)
Original Assignee
Univ Maryland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Maryland filed Critical Univ Maryland
Publication of IL141563A0 publication Critical patent/IL141563A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Transplantation (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL14156399A 1998-09-14 1999-09-09 Pharmaceutical compositions containing zot or zonulin IL141563A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10026698P 1998-09-14 1998-09-14
PCT/US1999/018842 WO2000015252A1 (en) 1998-09-14 1999-09-09 Method of using zot or zonulin to inhibit lymphocyte proliferation in an antigen-specific manner

Publications (1)

Publication Number Publication Date
IL141563A0 true IL141563A0 (en) 2002-03-10

Family

ID=22278888

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14156399A IL141563A0 (en) 1998-09-14 1999-09-09 Pharmaceutical compositions containing zot or zonulin
IL141563A IL141563A (en) 1998-09-14 2001-02-21 Pharmaceutical preparation containing zot or zoniolin

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL141563A IL141563A (en) 1998-09-14 2001-02-21 Pharmaceutical preparation containing zot or zoniolin

Country Status (17)

Country Link
EP (1) EP1113813B1 (es)
JP (1) JP2002524531A (es)
KR (1) KR100615442B1 (es)
CN (1) CN1228084C (es)
AT (1) ATE296110T1 (es)
AU (1) AU754142B2 (es)
CA (1) CA2342771A1 (es)
DE (1) DE69925496T2 (es)
ES (1) ES2239480T3 (es)
HU (1) HUP0103965A3 (es)
IL (2) IL141563A0 (es)
MX (1) MXPA01002600A (es)
NO (1) NO20011253L (es)
NZ (2) NZ510150A (es)
RU (1) RU2214271C2 (es)
WO (1) WO2000015252A1 (es)
ZA (1) ZA200102071B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6458925B1 (en) * 1998-08-03 2002-10-01 University Of Maryland, Baltimore Peptide antagonists of zonulin and methods for use of the same
EP2062909A1 (en) * 2007-11-21 2009-05-27 SOLVAY (Société Anonyme) Peptide production and purification process

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5945510A (en) * 1997-05-21 1999-08-31 University Of Maryland, Baltimore Substantially pure zonulin, a physiological modulator of mammalian tight junctions

Also Published As

Publication number Publication date
WO2000015252A1 (en) 2000-03-23
EP1113813A4 (en) 2002-05-29
NZ510150A (en) 2002-10-25
HUP0103965A2 (hu) 2002-03-28
RU2214271C2 (ru) 2003-10-20
DE69925496D1 (de) 2005-06-30
KR20010075114A (ko) 2001-08-09
MXPA01002600A (es) 2002-04-08
CN1317975A (zh) 2001-10-17
CA2342771A1 (en) 2000-03-23
HUP0103965A3 (en) 2004-06-28
EP1113813A1 (en) 2001-07-11
AU754142B2 (en) 2002-11-07
ZA200102071B (en) 2002-02-25
NO20011253L (no) 2001-03-15
ATE296110T1 (de) 2005-06-15
AU6019099A (en) 2000-04-03
NO20011253D0 (no) 2001-03-13
DE69925496T2 (de) 2006-02-02
JP2002524531A (ja) 2002-08-06
NZ521410A (en) 2005-06-24
IL141563A (en) 2006-06-11
CN1228084C (zh) 2005-11-23
ES2239480T3 (es) 2005-09-16
EP1113813B1 (en) 2005-05-25
KR100615442B1 (ko) 2006-08-25

Similar Documents

Publication Publication Date Title
NO974258D0 (no) IL-17-reseptor
Maestroni et al. Beta-endorphin and dynorphin mimic the circadian immunoenhancing and anti-stress effects of melatonin
Weitzmann et al. T cells: unexpected players in the bone loss induced by estrogen deficiency and in basal bone homeostasis
EP0865293A4 (en) DISABILITY OF T LYMPHOCYTE SUPPRESSION RELATED TO CTLA-4 SIGNAL TRANSMISSION
BG103948A (en) The use of cd40:cd154 binding interrupter to prevent counteradaptive immune responses, particularlynt counteradaptive immune responses, particularly graft rejection graft rejection
NZ504894A (en) Crystalline vaccine and adjuvant compositions jointly and separately administered to animals using a transdermal or transmucosally delivery technique
MY110217A (en) Use of l-deprenyl for retarding deterioration due to aging in dogs
AU3121497A (en) Methods of treating type i hypersensitivity using monophosphoryl lipid
EP0631502A4 (en) REGULATION OF LYMPHOCYTE ACTIVITY USING HLA PEPTIDES.
Kuppner et al. Ifosfamide impairs the allostimulatory capacity of human dendritic cells by intracellular glutathione depletion
EP0859625A4 (en) COMPOSITION AND METHODS FOR ENHANCING IMMUNE RESPONSES DUE TO ANTIGEN PRESENTING CELLS
NO996274D0 (no) CD154-blokkering for terapeutisk protein-inhibitorsyndrom
AU6819600A (en) Use of cd28 specific monoclonal antibodies for producing a pharmaceutical composition for treating virus infections
IL141563A0 (en) Pharmaceutical compositions containing zot or zonulin
EP0753005A4 (en) REGULATION OF CYTOTOXIC T LYMPHOCYTE ACTIVITY BY CLASS I MHC PEPTIDES
AU7161098A (en) Combinations of antigen and mucosal binding component for inducing specific immunological tolerance
AU1191795A (en) Deuterated active substances in transdermal application
AU5211200A (en) Method for diminishing specific immune reactions
Hildebrandt et al. Inhibition of dipeptidyl peptidase IV (DP IV, CD26) activity abrogates stress‐induced, cytokine‐mediated murine abortions
de Arruda Hinds et al. Modulation of B-lymphocyte and NK cell activities by glycoinositolphospholipid purified from Trypanosoma cruzi
WO2000000825A3 (en) Detection and modulation of cellular immunity to immune privileged antigens
SE0301846D0 (sv) Use of certain compounds in treatment of obesity
BR0308654A (pt) Compostos imunossupressores, métodos e usos relacionados a eles
HK1021318A1 (en) Lo-cd2a antibody and uses thereof for inhibiting t cell activation and proliferation
Wersäll et al. Interleukin-4 augments the cytotoxic capacity of lymphocytes and monocytes in antibody-dependent cellular cytotoxicity

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed